BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2673775)

  • 1. Treatment of hypercalcemia.
    Attie MF
    Endocrinol Metab Clin North Am; 1989 Sep; 18(3):807-28. PubMed ID: 2673775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of severe hypercalcemia.
    Davis KD; Attie MF
    Crit Care Clin; 1991 Jan; 7(1):175-90. PubMed ID: 2007213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiology and management of severe hypercalcemia.
    Nussbaum SR
    Endocrinol Metab Clin North Am; 1993 Jun; 22(2):343-62. PubMed ID: 8325291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Palliative therapy in cancer. 4. Palliation of the symptoms from a malignant tumor. (2)].
    Urushizaki I
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1525-35. PubMed ID: 1697156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hypercalcemic crisis. Exacerbation of an existing hypercalcemia syndrome].
    Hehrmann R
    Fortschr Med; 1996 Apr; 114(10):118-22. PubMed ID: 8655116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer-induced hypercalcemia.
    Lumachi F; Brunello A; Roma A; Basso U
    Anticancer Res; 2009 May; 29(5):1551-5. PubMed ID: 19443365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Medical treatment of malignant hypercalcemia].
    Eto S; Nakano Y; Okada Y
    Gan To Kagaku Ryoho; 1993 Dec; 20(15):2311-8. PubMed ID: 8259844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypercalcemia of malignancy in the palliative care patient: a treatment strategy.
    Kovacs CS; MacDonald SM; Chik CL; Bruera E
    J Pain Symptom Manage; 1995 Apr; 10(3):224-32. PubMed ID: 7543127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The medical treatment of primary hyperparathyroidism].
    Lo Cascio V; Rossini M; Bertoldo F
    Recenti Prog Med; 1993 Apr; 84(4):287-95. PubMed ID: 8488334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical treatment of hypercalcemia.
    Schaiff RA; Hall TG; Bar RS
    Clin Pharm; 1989 Feb; 8(2):108-21. PubMed ID: 2521820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium and vitamin D supplementation during bisphosphonate administration may increase osteoclastic activity in patients with bone metastasis.
    Altundag O; Altundag K; Selim Silay Y; Gunduz M; Demircan K; Gullu I
    Med Hypotheses; 2004; 63(6):1010-3. PubMed ID: 15504568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcitonin therapy in prolonged immobilization hypercalcemia.
    Carey DE; Raisz LG
    Arch Phys Med Rehabil; 1985 Sep; 66(9):640-4. PubMed ID: 4038033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of immobilization hypercalcemia using calcitonin and etidronate.
    Meythaler JM; Tuel SM; Cross LL
    Arch Phys Med Rehabil; 1993 Mar; 74(3):316-9. PubMed ID: 8439262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of malignancy-associated hypercalcemia].
    Endo I; Inoue D
    Clin Calcium; 2006 Apr; 16(4):665-69. PubMed ID: 16582519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
    Onuma E; Azuma Y; Saito H; Tsunenari T; Watanabe T; Hirabayashi M; Sato K; Yamada-Okabe H; Ogata E
    Clin Cancer Res; 2005 Jun; 11(11):4198-203. PubMed ID: 15930357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current management strategies for hypercalcemia.
    Pecherstorfer M; Brenner K; Zojer N
    Treat Endocrinol; 2003; 2(4):273-92. PubMed ID: 15966562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hypercalcemia in malignancy].
    Eto S
    Rinsho Byori; 1994 Sep; 42(9):943-51. PubMed ID: 7967119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of hypercalcemia in breast cancer.
    Theriault RL
    Oncology (Williston Park); 1990 Feb; 4(2):43-6; discussion 50. PubMed ID: 2143669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.